BIP48

Peginterferon alfa-2b (48 kDa pegylated form) · The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIP48, covering 2012-06-20 to 2012-06-20. Get the full timeline:

Most recent: Clinical Trial Update: BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis C [Phase 2, Phase 3]

See pricing